Literature DB >> 23421238

Nanoencapsulation and characterization of zidovudine on poly(L-lactide) and poly(L-lactide)-poly(ethylene glycol)-blend nanoparticles.

Rubiana Mara Mainardes1, Maria Palmira Daflon Gremião.   

Abstract

In this work, the antiretroviral zidovudine was encapsulated on biodegradable poly(L-lactide) (PLA) or poly(L-lactide)-poly(ethylene glycol) (PLA-PEG)-blend nanoparticles by the double-emulsion solvent-evaporation method. The PLA-PEG blend was obtained by the physical mixture of the isolated polymers in organic solvent, whose PEG content ranges from 5 to 50 g in the blends. The physicochemical characteristics of the nanoparticles were evaluated applying particle-size and zeta-potential analyses, scanning electron microscopy, differential scanning calorimetry and Fourier-transform infrared spectroscopy. The release rate of zidovudine from the nanoparticles was investigated as well. The drug encapsulation efficiencies were around 50%, and the mean diameters of the nanoparticles were less than 400 nm. The PEG presence influenced all of the analyzed physicochemical parameters. The amount of drug released increases with the PEG presence in the blend. Therefore, the investigated nanoparticles are very promising carriers for zidovudine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23421238     DOI: 10.1166/jnn.2012.6638

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  7 in total

1.  Glycerol monolaurate nanocapsules for biomedical applications: in vitro toxicological studies.

Authors:  Leonardo Quintana Soares Lopes; Pablo Sebastian Britto de Oliveira; Walter Paixão de Souza Filho; Rodrigo de Almeida Vaucher; Janice Luehring Giongo; Michele Rorato Sagrillo; Roberto Christ Vianna Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-11       Impact factor: 3.000

Review 2.  Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.

Authors:  Jingwei Shao; John C Kraft; Bowen Li; Jesse Yu; Jennifer Freeling; Josefin Koehn; Rodney Jy Ho
Journal:  Nanomedicine (Lond)       Date:  2016-02-19       Impact factor: 5.307

Review 3.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 4.  Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention.

Authors:  Ravindra K Gupta; David A M C Van de Vijver; Sheetal Manicklal; Mark A Wainberg
Journal:  Retrovirology       Date:  2013-07-31       Impact factor: 4.602

5.  Stabilized nanosystem of nanocarriers with an immobilized biological factor for anti-tumor therapy.

Authors:  Angelika Kwiatkowska; Ludomira H Granicka; Anna Grzeczkowicz; Radosław Stachowiak; Michał Kamiński; Zuzanna Grubek; Jacek Bielecki; Marcin Strawski; Marek Szklarczyk
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 6.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04

7.  Resveratrol-loaded polymeric nanoparticles: validation of an HPLC-PDA method to determine the drug entrapment and evaluation of its antioxidant activity.

Authors:  Gabriela da Rocha Lindner; Najeh Maissar Khalil; Rubiana Mara Mainardes
Journal:  ScientificWorldJournal       Date:  2013-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.